Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Feraccru (ferric trimaltol; Shield Therapeutics/AOP Orphan Pharmaceuticals) Drug Analysis 2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Feb 18

The "Drug Analysis: Feraccru" drug pipelines has been added to ResearchAndMarkets.com's offering.

Feraccru (ferric trimaltol; Shield Therapeutics/AOP Orphan Pharmaceuticals) is a novel oral ferric iron form with hematinic activity being investigated for the treatment of anemia in chronic kidney disease (CKD). The drug dissociates into ferric iron which is transported to erythroid precursor cells to be incorporated into hemoglobin. Feraccru is awaiting approval in Europe for the treatment of anemia in CKD in inflammatory bowel disease, as an alternative to intravenous iron.

Key Topics Covered:

List of Figures

Figure 1: Feraccru for anemia in chronic kidney disease - SWOT analysis

Figure 2: Drug assessment summary of Feraccru for anemia in chronic kidney disease

Figure 3: Drug assessment summary of Feraccru for anemia in chronic kidney disease

Figure 4: Feraccru sales for anemia in chronic kidney disease across the US, Japan, and five major EU markets, by country, 2015-24

List of Tables

Table 1: Feraccru drug profile

Table 2: Feraccru Phase III trials in anemia in chronic kidney disease

Table 3: Feraccru sales for anemia in chronic kidney disease across the US, Japan, and five major EU markets, by country ($m), 2015-24

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/wqg6zr/feraccru_ferric?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180219005524/en/

Business Wire
www.businesswire.com

Last updated on: 19/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.